It is known that MM patients with SOX2 expression have a worse overall survival than patients without SOX2 expression (45), and this report is compatible with our previous finding that MM patients with low CD138 expression showed a poor prognosis (9). This evidence concerns the gene SDC1 and Miyoshi myopathy.